An essential step in the development of products based on biotechnology is an assessment of their potential economic impacts and safety, including an evaluation of the potential impact of transgenic crops and practices related to their cultivation on the environment and human or animal health. The purpose of this paper is to provide an assessment method to evaluate the impact of biotechnologies that uses quantifiable parameters and allows a comparative analysis between conventional technology and technologies using GMOs. This paper introduces a method to perform an impact analysis associated with the commercial release and use of genetically modified plants, the Assessment System GMP Method. The assessment is performed through indicators that are arranged according to their dimension criterion likewise: environmental, economic, social, capability and institutional approach. To perform an accurate evaluation of the GMP specific indicators related to genetic modification are grouped in common fields: genetic insert features, GM plant features, gene flow, food/feed field, introduction of the GMP, unexpected occurrences and specific indicators. The novelty is the possibility to include specific parameters to the biotechnology under assessment. In this case by case analysis the factors of moderation and the indexes are parameterized to perform an available assessment.
Introduction
An essential step for the development of a genetically modified plant (GMP) is the assessment of its safety. This procedure evaluates all possible influences of the plant and practices related to its cultivation on the environment and on human or animal health. This is accomplished through adequate comparisons between the target of genetic manipulations and organisms with similar traits, for example, wild genotypes of the plant used to produce the GMP. This evaluation is performed by impact analysis.
The GMP impact assessment, in general, may be a helpful tool for decision-making process. Search engines and systemized data compression tools, which allow the generation of traceable conclusions, are keyelements to assure that the decision-making process culminates in the appropriate biotechnology management, with the best resources and results. This study proposes a methodological system to evaluate the impacts of biotechnologies, providing information organized according to criteria and indicators of several areas where the impact can be perceived in a direct or indirect manner: social, economic, environmental, institutional and capacity development (General Assessment); genetic insert features, GM plant features, gene flow, food/feed field, introduction of the GMP, unexpected occurrences and specific indicators (Technical Assessment).
The proposed system is based on previous methods of risk analysis and impact assessment, such as GMP-RAM METHOD -Risk Assessment Method for Genetically Modified Plants (Jesus et al., 2006) , INOVA-tec System -Impact Assessment System for Technological Innovation (Jesus-Hitzschky, 2007) and Environmental Impact Assessment methods utilized during ISO 14000 implementation. Many validated issues or parameters of analysis described in previous reports (EFSA, 2006; OCDE, 2005; FAO, 2004; Conner et al., 2003; NAS, 2002) were also considered. The AS-GMP Method allows the evaluator to point out the specific parameters to evaluate his/her biotechnology enabling the analysis of each particular case, so that the GMP can be applied in a responsible and sensible way.
This information is organized into three tools: (1) worksheets to compile Prospective Range, through the Significance Index; (2) indicators worksheets to compile an Impact Level Performance defined by the Magnitude Index. Finally the combination of both Indexes (Significance × Magnitude) designs the (3) Matrix of Impact that is built by the General Impact Value. The AS-GMP Method works as a guide pointing to indicators which should be analyzed and to the components that may have some importance in the evaluation hence the method contributes to reduce subjectivity.
In this way it allows, as a whole, the reduction of negative impacts, and the best use of resources for GMP introduction so that the prevention and mitigation of environmental damages can be achieved.
All activities related to commercial release, field trial tests, greenhouse experiments, or even lab assays with GMP are evaluated by AS-GMP method. Therefore, the method can be used throughout GMP development, from the researcher during new trait search to the regulators during assessment for market clearance. Obviously, the exchange of information and experience among all involved parts allows an accurate analysis of GMP safety. The method can be used by program and project evaluators, managers and also regulatory and supervisory agencies. To allow a better comprehension of this system, it is presented in a digital format 1 (AS-GMP Method v.1.0. Software) and its three tools are linked so that the user can fill the information in the worksheets and automatically observe the results in tables, graphics and matrices. It also presents a conclusive report.
Transgenic crop environment and AS-GMP Method
The main purpose of the method is to improve the rapid evaluation of possible impacts of the commercialization of transgenic crops, compatible with the existing restraints put on costs and time by the situation of the majority of Biotechnology Safety Committees, mostly in developing countries.
2 However, the method allows evaluating exante and ex-post the development of GMP on the market, contributing to the concept of sustainability (Fig. 1) . The AS-GMP Method has a low cost, but allows a wide evaluation, showing the indicators at several levels. It is also able to act directly within the scope of research institutions and biotechnology companies, and to indirectly promote the discussion of proposition of new biotechnology policies. A spin-off of AS-GMP Method is the adequacy or generation of public and
Research & Development policies more suitable to the innovative process, in a way that the comprehensive assessment of biotechnology allows a rational environmental management allied with the accountability of clearness in the results. Fig. 1 is a schema of AS-GMP Method, showing its potentiality of use by several actors, interests and assessment timing. In case the assessment has a prospective interest the analysis must be done exante the technology use, focusing on the 'Prospective Range' and illustrating its focus on potential impacts assessment.
It is possible to point out why probably there would be more interest in this kind of analysis: funding agencies, investors and decision-makers, in order to decide among a project portfolio or what is the range of a funded innovation. The assessment ex-post of the innovation development foresees the assessment of all indicators, gathered in accordance with the assessment criteria on its fields and which analysis allows the clarification of 'Impact Level Performance'. The analysis of the range or prospective assessment and the choice of the Indicators of Performance in order to prepare the structure of the impact matrix and therefore to elaborate the 'GMP Scenario' is part of general impact assessment. The general analysis of impacts and GMP scenario must be the focus of the analysis made by regulatory and supervisory agencies, technology buyer companies and society on the whole.
The cost of regulatory release and compliance is already the most important roadblock for public goods research projects in this field (De Greef, 2004) . Alternative approaches to regulate new crop biotechnologies could be less expensive, but to date the private and social costs of the current regulatory system have not been analyzed or measured, let alone compared with alternatives (Kalaitzandonakes et al., 2007) . The AS-GMP Method/Software will be available cost-free at Embrapa Meio Ambiente (Environment) website. It will impact favorably the biosafety assessments for regulatory submissions since the method indicates the most important parameters that have to be addressed in researches or experiments, avoiding data duplication which gathers needless requirements and wastes biosafety assessment money.
The description of the AS-GMP Method

Biotechnology characterization
In order to carry out biotechnology assessment first of all it is recommended to perform the GMP characterization in order to assure 1 Soon available for download at the website of Embrapa Meio Ambiente: http:// www.cnpma.embrapa.br/forms/as_gmp.php3.
2 The Multicriteria Analysis can be seen as a more sophisticated alternative to rapid appraisal approaches. According to Zackiewicz (2005) , Multicriteria Analysis framework has been developed as an aid for evaluating decisions, choices that could provide a basis for ex-ante selection of projects related to biotechnology and the diffusion of GMP. Though, it has an impact evaluation perspective, hence, an ex-post approach. However, the two kinds of evaluation must be used in their own time for a better possible achievement on the research effort allocation, improving public research portfolio choices. This kind of approach uses a specifically developed methodology to integrate economic with environmental, social, and building capability dimensions. The progress of the assessment of these new frameworks have allowed to evaluate problems raised on the treatment of economic impacts, when one moves away from the Cost-benefit analysis and Cost-effectiveness to a more comprehensive framework. a proper assessment report and hereby attendance and monitoring of its application performance. The necessary information to collect the most relevant data in order to assure acuity of assessment is presented below. This information is presented on the first page of AS-GMP Software.
Information about GM plant
2.2.1. Description of the trait(s) and characteristics which have been introduced or modified A description of the trait and the changes it produces on the plant phenotype is required (EFSA, 2006) . Phenotypic modifications should be quantified in relation to the comparable non-GM plant. The targets of the trait should be identified as well as the sensitivity of nontargets. The purposes of the genetic modification and the uses of the GM crop should be described together with changes in the crop composition, management, cultivation, deployment, geographic range and end use.
Information on the sequences actually inserted or deleted
Applicants should provide information on (EFSA, 2006) : (a) the size and number of copies of all detectable inserts, both complete and partial; (b) the organization of the inserted genetic material at the insertion site and methods used for the characterization; (c) in case of deletion(s), size and function of the deleted region(s); and (d) sub-cellular location(s) of insert(s) (nucleus, chloroplasts, mitochondria maintained in a nonintegrated form) and methods for its determination.
Genomic databases for the crop species
With regard to flanking sequences in general the GMO panel is aware that comparative sequence analysis may not always be possible due to limited genomic databases for the crop species in question.
Methods used for expression analysis
The methods used for the analysis of gene and protein expression must be provided. 
Genetically modified plants assessment
The assessment is performed through the analysis of indicators which are arranged according to their area criteria (coded with letters) in two ways: general or technical such as: environmental (A), institutional (B) capacity development (C), economic (D), social (E) (General Assess); genetic features (F), GM plant features (G), gene flow (H), food/feed field (I), introduction of the GMP (J), unexpected occurrences (K) and specific indicators field (L) (Technical Assess). The novelty is the possibility to add specific parameters to the GMP under assessment. In this case by case analysis the factors of moderation and the indexes are parameterized to run helpful assessment. Three tools support the Proposed Impact Assessment Method for Genetically Modified Plant 'AS-GMP Method': (a) worksheets to compile the Prospective Range, through the Significance Index; (b) indicator worksheets to compile an Impact Level Performance defined by the Magnitude Index. Finally the combination of both 
General Assessment
The first tool identifies a prospective analysis of the objective related to the use of a specific biotechnology. In this phase of assessment the following moderation factors are considered: spatial range, reach and influence. This first part of the assessment may be used in ex-post assessment as well as in ex-ante assessment, either by an evaluator who is going to decide about a GMP application or by funding agencies/ investors which are going to choose among biotechnology projects when deciding the destination of financial resources.
These moderation factors are showed in a worksheet that gives values to the importance and significance of the factor in terms of the Extent of its use -local, regional, national and international -and the direct or indirect Scope of their application (environment, human health, product or process quality, social, economic, political and legal). The analysis of these ( Creation (2)/ The innovation is a biodegradation mechanism that recovers a degraded area.
Improvement (1) Give (+ 1) one point to each training carried out for the development of the innovation.
Number of participants: Up to 10% of the employees of the organization (+1) / over 10% (+ 2) Scientific production 2 Defended MSc dissertations associated to the innovation.
Give one point for each finished dissertation related to the innovation (+1) 2
Defended PhD theses associated to the innovation.
Give one point for each finished thesis related to the innovation (+ 1). 2 Scientific papers published in national or international journals of the innovation sector.
Give one point for each published paper related to the innovation (+ 1)
Factor 1 Factor 2 Another sector (+1)/ same sector (+2)
Number of abstracts in proceedings and presentations in conferences.
Give (+ 1) one point for each presented work related to the innovation. No (0) a Potential impact (ex-ante): indicators used for ex-ante technology assessment.
moderation factors allows the generation of the Significance Index Gen (Table 1) . It is given a range of values to each moderation factor of innovation. Each weight given to the moderation factors will be considered for the generation of the Significance Index Gen , according to the formula below:
Σ Scope a;g × Influence a;g = Biotechnology Range
Biotechnology Range × Extent = Significance Index Gen :
2.3.2. Worksheets to compile the Scenario for the GMP Introduction: the Significance Index tech -Technical Assessment The scenario of the GMP is composed of safety information that has been already searched in a laboratory essay or based in the literature (Table 2) : i) data/tests of the genetic insertion safety; ii) tests of stability of the insertion, iii) tests of stability of the new feature, and iv) evaluation of agronomic applications, tests of innocuity of the new product (aimed at a pharmaceutical or cosmetic), or tests of feed safety (substantial equivalence). In the item iv) just one characteristic must be filled. Each weight given to moderation factors will be considered for the generation of the Significance Index tech , according to the formula below (Tables 3-5 field and enable users to fill in values related to the level of importance or magnitude of the parameters. The goal of this method creation is to consider the indicators assessment within every possible field, without privileging any parameter. In this way, AS-GMP Method foresees the regulation of weights, but does not prioritize fields.
In case of an ex-post assessment, the indicators worksheet must be fully evaluated, whereas in case of an assessment ex-ante the 
Yes (− 1)/no (0)
Information on the expression of the insert 2 Information on developmental expression of the insert during the life cycle of the plant Improves (1)/maintains (0)/worsens (− 1) 2 Changing in biology and agronomic traits, including common breeding parameters (e.g. plant morphology, flowering time, duration of pollen viability).
Yes (− 1)/no (0) 2 Expression of potential fusion proteins (should be investigated by bioinformatic analysis) Yes (− 1)/no (0) 2 Changes in susceptibility to important pests and diseases. Increase (− 1)/decrease (1)/does not alter (0) Mechanism of interaction between the GM plant and target organisms 2 Expression and mode of action is specific to target organism of any new traits present in the modified plant.
Specific (1)/non-specific (− 1)/there is no target organism in the event (0) Interactions between the GM plant and its biotic environment 2 Effects on the numbers and diversity of relevant populations of species in the receiving environment (plant, animal, microbe); Effects on beneficial plant-microbial associations and biogeochemistry (biogeochemical cycles), particularly on microbial-mediated carbon and nitrogen recycling through changes in soil decomposition of organic material.
Yes (1)/no (0)
Potential interactions with the abiotic environment 2 Alteration of climatic conditions (e.g. altered production of greenhouse gases). Improves (1)/maintains (0)/worsens (− 1) 2 Altered sensitivity to, or tolerance of climatic conditions (e.g. cold, heat, humidity). Improves (1)/maintains (0)/worsens (− 1) 2 Altered sensitivity to, or tolerance of abiotic fractions of soil (e.g. salinity, mineral nutrients, mineral toxins).
Improves (1)/maintains (0)/worsens (− 1) 2 Altered sensitivity to, or tolerance of gases (e.g. CO 2 , oxygen, NH 3 ). Improves (1)/maintains (0)/worsens (− 1) 2 Alteration of mineralization (e.g. root exudates changing the soil pH). Improves (1)/maintains (0)/worsens (− 1)
Persistence and invasiveness 2 GM plant becomes more persistent or invasive than the non-GM counterpart. Yes (− 1)/no (0) 
Fields for indicator description, indicator weight, factors of moderation and criteria of assessment
On the worksheet the parameter or indicator under assessment is grouped within its field according to its criterion or characteristic. These items are predetermined on the worksheet in order to allow an accurate evaluation of related impacts.
These summarized data on the indicators worksheet were identified and compiled with the contribution of experts from several areas of the assessment approach. This counsel was carried out through personal interviews, with the purposes of: firstly to identify and consolidate the necessary indicators and thereafter to make adjustments on indicators' weights and weight ranges of each moderation and correction factors, when necessary. Some tests were accomplished for adjustments not only on used parameters but also on the functionality of the support Software for the system application.
To each indicator presented on Tables 6-17 the method gives a weight, which varies from 1 to 3. This variation in weight is done as follows: indicators that show a higher weight are the ones with potentialized impact. For example, in the case of Environmental Field the indicators of environment recovery have weight 3, since according to this item a certain environment may be recovered potentializing its future use for conservation or preservation. On the same way, it is given the maximum value (3) to the field 'unexpected events' since it brings the possibility of adverse or undesirable effects. On the other hand, indicators added by users have weight 1, so that the final result does not suffer great distortions.
In spite of creating a hierarchy within each field, this will not be used for the decision-making but for a scenario generation and so the general panorama of the GMP environment. In this way, the fields' weights are the same, since they are considered equally important. In other words, the biotechnology assessment should contemplate the use of AS-GMP Method in each of its fields. In case an indicator is not significant for the GMP under analysis it should be ignored, in the same way more specific new indicators for the evaluation can be added to the field "Specific indicators". Increases needs (− 1)/decreases needs (1)/does not alter ( Commercial management regimes 2 Changes on applications of plant protection products (pesticides and/or biocontrol agents), for the GM plant where these are different from the equivalent non-GM plant.
Increases needs (− 1)/decreases needs (1)/does not alter (0) 2 Changes on rotations and other plant management measures for the GM plant where these are different from the equivalent non-GM plant.
Improves (1)/maintains (0)/worsens (− 1) Table 15 Worksheet of indicators to compile an Impact Level Performance: the Magnitude Index Tech -GMP introduction field (J).
Weight Indicator/moderation factor Data/information for evaluation Factor's weight range Aiming to provide an accurate evaluation it is possible to ignore some fields or to perform just one kind of analysis either General or Technical because the results are presented separately. Otherwise it is suggested that the whole analysis bound is executed in order to have a complete assessment.
Data/information for the evaluation field
This central column is the field where the user describes all information related to the criterion of assessment. Literature searches or prospective data must be the source of scientific data, described to perform the ex-ante analysis or the scenario elucidation of the GMP. Experimental results from GMP application must be used as the assessment basis, that is, for weight allocation. These collected data must be inserted in the worksheet's central column in order to ensure the acuity and support of the achieved results.
These data will be shown on methodology results in electronic format (AS-GMP v1.0 Software) as a 'descriptive report'.
Matrix of impact that is built by the General/Technical Impact Value
The third tool provides a structure to observe the potential impact and the prospective scenario to introduce the GMP, in the ex-ante analysis. In the ex-post evaluation, that uses the Significance Index and all indicators to build the Magnitude Index. These both indexes are crossed to show the final result form: the analysis in a matrix format (Figs. 2 and 3) .
After the identification of the technology scope, GMP characterization, impact assessment, and the significance analysis of related effects, the final step in this impact assessment process comes inreviewing the potential impact and establishing at which level impact management, through preventive or corrective actions, must be taken in order to allow an effective and safe use of the transgenic crop. This is performed by the Matrix of Assessment.
The Matrix (Figs. 2 and 3 ) is constructed with two axes, where the xaxis stands for the classes of the Index of Magnitude (indicators performance) and the y-axis stands for the classes of the Significance Index (Prospective Analysis/Scenario for the GMP Introduction). That is indicated in the matrix 'General/Technical Impact Value', which is the final result of all indicators of all fields. To complement the evaluation the results from the Magnitude and Significance Indexes for each field are plotted in the Matrix according to their position (points are plotted using letters that represent each field). The general value for the field performance is the result of the sums of all indicator values inside the field under evaluation. The illustration of this result of the field evaluation (plotting the letters like a code) allows formulating a list of recommendations with the objective of potentializing a positive impact of the GMP on each field. This measure favors the first proposition of the system: fields should be considered equally important, and thus corrective measures should be taken in order to mitigate distortions of impacts between them.
The level of performance of the technology under evaluation is classified as follows:
(1) Prospective assessment: unfavorable scenario to the GMP/GMP in early implementation stage (potential impact assessment) or with low perspective of success -GMP is not recommended. (2) Prospective assessment: unfavorable scenario to the GMP/GMP with low performance -restrictions and corrective actions are recommended to the GMP. (3) Prospective assessment: unfavorable scenario to the GMP/GMP with medium performance -monitoring with restrictions is recommended to the GMP. (4) Prospective assessment: unfavorable scenario to the GMP/GMP with excellent performance -GMP is recommended. (5) Prospective assessment: favorable scenario to the GMP/GMP in early implementation stage (potential impact assessment) or with low perspective of success -management with restrictions is required. (6) Prospective assessment: favorable scenario to the GMP/GMP with low performance -corrective actions are recommended to the GMP. (7) Prospective assessment: favorable scenario to the GMP/GMP with medium performance -monitoring or management is required to the GMP. (8) Prospective assessment: favorable scenario to the GMP/GMP with excellent performance -GMP recommended. (9) Prospective assessment: favorable scenario to the GMP -investments in the GMP are recommended/GMP low performancemanagement required.
(10) Prospective assessment: scenario favorable scenario to the GMPinvestments are recommended/GMP low performance -management required. (11) Prospective assessment: favorable scenario to the GMPinvestments are recommended/GMP medium performancemonitoring required. (12) Prospective assessment: favorable scenario to the GMP -investments are recommended-GMP excellent performance -GMP highly recommended.
2.7. Digital format -introduction of the software AS-GMP (V. 1.0)
The software AS-GMP v. 1.0 is an electronic format of the worksheets, created in Microsoft Visual Basic v. 6.0, which can be accessed at Embrapa Environment link: http://www.cnpma.embrapa. br/forms/as_gmp.php3 (GMP impact assessment file to download). To run the AS-GMP, just download the file to your PC and run it with a double click. Fig. 2 . The Matrix of General Assessment is the first step of this Impact Assessment tool. The Matrix of Assessment gives an overview of the general impact evaluation and establishes at which level impact management must be taken. The information that is considered in this Matrix (General) is the Significance Index gen (Prospective Range) and Magnitude Index gen (General Impact Index). The x-axis represents the classes of the Magnitude Index and the y-axis represents the classes of the Significance Index. 
Results
By using this electronic format, it is possible to attribute values to the factors of moderation on the worksheets and to the results of the indexes (Significance and Magnitude). Those will be calculated and plotted in the Matrix of Impact automatically. These results can be presented in table or graph format and also in the description report.
Compiled analysis
The following step involves compiling and analyzing the results from the matrix and worksheets. Each field coded with a letter is plotted in the matrix aiming to require some measures according to the level of impact. These impact measures must consider all data described in the worksheet, such as the specificity of the GMP, the activity under analysis, release concerns and the scenario situation. Essentially, this compilation is the core structure for performing impact management.
Aiming to potentialize the positive impact of the GMP on different fields, the code that represents each field is plotted in the matrix's row compatible with its performance. The visual and graphic data presentation format facilitates to suggest corrective measures for its optimization or mitigation of negative impacts. Therefore, for a proper evaluation the user needs to formulate his/her list of recommendations specific to the GMP under analysis.
Conclusions
Prospective analysis must be carried out to predict the occurrence of negative impacts of some GM crops on the environment or on human health. Additionally, this analysis must forecast and optimize economic, capability, institutional or social success. These assessments allow us to define preventive measures to mitigate or avoid negative effects related to genetic insert features, GM plant features, gene flow, food/feed field, introduction of GMP, unexpected occurrences and specific indicators that could result in negative impacts.
This rapid appraisal allows us to define preventive measures to mitigate or avoid adverse effects or unexpected occurrences that could result from potential or identified hazards. Thus, it is possible to develop a transgenic crop with a high probability of success and safety.
The impact assessment proposed here includes parameters that allow an estimate of the performance level, which is based on the assignment of numeric values to several factors correlated with impact. It results in lower subjectivity and higher clearness in the analysis processes. Technologies with the same objectives can also be compared using the proposed system. Considering the range of different genetical modifications to be evaluated and the performance behaviors and safety concerns that must be addressed on a case by case basis, the proposed system may not cover all aspects involved, though it presents a broad approach to impact assessment. Since there is always a likelihood of development of a new and better method that could be used in many situations, the user is encouraged to expand the possibilities of this tool by adding or deleting parameters according to the kind of technology addressed. On the other hand, investors and regulators must evaluate whether the chosen parameters are the best to define the potential impact of the GMP under analysis.
This strategy is very important to allow a less superficial method, since it is able to identify which parameters are more correlated with the transgenic crop. In addition, characterizing impact by measuring it with quantifiable tools demonstrates a quantitative method where subjectivity is drastically reduced. Compared to current processes, the proposed method represents a less subjective and clearer process for impact assessment.
